| |
Health Communication, Vol. 16, No. 2. (2004), pp. 131-157.
|
| |
JAMA, Vol. 293, No. 16. (27 April 2005), pp. 1995-2002.
|
| |
Molecular systems biology, Vol. 2 (3 October 2006)
|
| |
Pharmaceutical research, Vol. 23, No. 6. (June 2006), pp. 1075-1088.
|
| |
Genome medicine, Vol. 1, No. 1. (22 January 2009)
|
| |
Nat Rev Drug Discov, Vol. 8, No. 10. (18 September 2009), pp. 779-782.
|
| |
The Journal of Organic Chemistry, Vol. 74, No. 19. (2 October 2009), pp. 7407-7410.
|
| |
CMAJ, Vol. 175, No. 4. (15 August 2006), 374.
|
| |
Ind Corp Change, Vol. 18, No. 4. (1 August 2009), pp. 729-759.
|
| |
PharmacoEconomics, Vol. 27, No. 5. (2009), pp. 431-432.
|
| |
Nucleic acids research, Vol. 36 (Database issue), No. Database issue. (11 January 2008), pp. D901-D906.
|
| |
The AAPS Journal, Vol. 10, No. 1. (22 March 2008), pp. 9-14.
|
| |
Nat Rev Drug Discov, Vol. 8, No. 6. (June 2009), pp. 451-451.
|
| |
|
| |
Nat. Prod. Rep., Vol. 26, No. 5. (2009), pp. 602-609.
|
| |
Drug Discovery Today: BIOSILICO, Vol. 2, No. 4. (July 2004), pp. 138-139.
|
| |
Pharmacology Biochemistry and Behavior, Vol. 86, No. 3. (March 2007), pp. 458-467.
|
| |
Thunderbird International Business Review, Vol. 50, No. 5. (2008), pp. 321-330.
|
| |
Strategic Management Journal, Vol. 23, No. 7. (2002), pp. 619-635.
|
| |
NMR in Biomedicine, Vol. 12, No. 2. (1999), pp. 69-97.
|
| |
J Clin Pharmacol, Vol. 48, No. 12. (1 December 2008), pp. 1389-1399.
by Prajakti A. Kothare, Helle Linnebjerg, Yoshitaka Isaka, et al.Kazunori Uenaka, Ayuko Yamamura, Kwee P. Yeo, de La, Choo H. Teng, Kenneth Mace, Mark Fineman, Hirofumi Shigeta, Yukikuni Sakata, Shin Irie
|
| |
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Vol. 35, No. 1-2. (2 September 2008), pp. 1-4.
|
| |
Nature Medicine, Vol. 13, No. 3., pp. 304-308.
|
| |
Vaccine, Vol. 25, No. 20. (16 May 2007), pp. 4003-4011.
|
| |
|
| |
Journal of Pharmaceutical Sciences, Vol. 91, No. 8. (2002), pp. 1853-1862.
|
| |
Journal of Intellectual Property Law Practice (10 April 2009), jpp048.
|
| |
Ind Corp Change, Vol. 18, No. 2. (1 April 2009), pp. 295-323.
|
| |
Chemical Engineering Science, Vol. 62, No. 5. (March 2007), pp. 1536-1542.
|
| |
Research Policy, Vol. 28, No. 2-3. (March 1999), pp. 179-193.
|
| |
ORGANIZATION SCIENCE, Vol. 20, No. 1. (1 January 2009), pp. 187-205.
|
| |
Strategic Management Journal, Vol. 20, No. 7. (1999), pp. 655-670.
|
| |
Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences, Vol. 37, No. 3. (September 2006), pp. 550-565.
|
| |
Proceedings of the Aristotelian Society (Hardback), Vol. 100, No. 1. (2000), pp. 193-208.
|
| |
|
| |
Journal of Generic Medicines, pp. 20-29.
|
| |
Strategic Management Journal, Vol. 15 (1994), pp. 63-84.
|
| |
Industry & Innovation, Vol. 15, No. 1. (2008), pp. 93-114.
|
| |
Strategic Organization, Vol. 6, No. 4. (1 November 2008), pp. 343-374.
|
| |
Drug Discovery Today, Vol. 9, No. 1. (January 2004), pp. 18-26.
|
| |
Health, Risk & Society, Vol. 4, No. 3. (2002), pp. 305-324.
|
| |
Sociology, Vol. 36, No. 1. (1 February 2002), pp. 67-88.
|
| |
Journal of International Management In Institutional Changes and Organizational Transformation in Developing Economies, Vol. 14, No. 3. (September 2008), pp. 252-269.
|
| |
Drug Discovery Today, Vol. 13, No. 13-14. (July 2008), pp. 584-589.
|
| |
J. Comb. Chem, Vol. 8, No. 5. (11 September 2006), pp. 664-669.
by H. N. Weller, D. S. Nirschl, E. W. Petrillo, et al.M. A. Poss, C. J. Andres, C. L. Cavallaro, M. M. Echols, K. A. Grant-Young, J. G. Houston, A. V. Miller, R. T. Swann
|
| |
Drug Discovery Today, Vol. 8, No. 9. (1 May 2003), pp. 411-420.
|
| |
Nat Rev Drug Discov, Vol. 1, No. 10. (October 2002), pp. 751-752.
|
| |
Biological & pharmaceutical bulletin, Vol. 25, No. 5. (May 2002), pp. 547-557.
|
| |
Technology Analysis and Strategic Management (May 2007), pp. 257-277.
|
| |
International Journal for Equity in Health, Vol. 7 (02 May 2008), 12.
|
Search
